Aditya Dandekar
Associate Director Cabaletta Bio
Aditya Dandekar is a senior biotechnology professional with over a decade of experience in immuno-oncology, liver disease, and rare skin disorders. His work has focused on driving innovation in cytokine-based cell therapies – reducing manufacturing times, improving product generation, and achieving significant cost savings. With strong leadership and cross-functional expertise across clinical, quality, and analytical teams, he is passionate about advancing immunotherapy and shaping the future of biotech through creative, impactful collaboration.
Seminars
Tuesday 27th October 2026
Reducing Process Risk by Defining the Variability You Can Still Proceed With
1:40 pm
- Defining acceptance criteria based on process characterization rather than supplier specifications
- Understanding when variability can be absorbed and when it becomes a process risk
- Disqualifying lots with confidence using data instead of assumptions
